Alnylam Pharmaceuticals reported $677.72M in Debt for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Agios Pharmaceuticals AGIO:US $ 1.22M 0.7M
Alnylam Pharmaceuticals ALNY:US $ 677.72M 1.01M
Amgen AMGN:US $ 36522M 332M
Arrowhead Research ARWR:US $ 0M 0M
Avrobio Inc AVRO:US $ 15.1M 84K
Biocryst Pharmaceuticals BCRX:US $ 622.18M 17.72M
Biomarin Pharmaceutical BMRN:US $ 1081.05M 0.99M
Bluebird Bio BLUE:US $ 0M 0M
Intercept Pharmaceuticals ICPT:US $ 713.86M 3.03M
IONIS PHARMACEUT IONS:US $ 1253.13M 1M
Mirati Therapeutics MRTX:US $ 0M 0M
Moderna Inc MRNA:US 762M 44M
Neurocrine Biosciences NBIX:US $ 169M 208.7M
Novartis NVS:US $ 31031M 244M
Ptc Therapeutics PTCT:US $ 1207.54M 10.46M
Regeneron Pharmaceuticals REGN:US $ 2700.7M 0.3M
Regulus Therapeutics RGLS:US $ 4.45M 0.03M
Sangamo Biosciences SGMO:US $ 0M 0M
Sarepta Therapeutics SRPT:US $ 1100.87M 2.03M
Takeda 4502:JP Y 4602254M 256843M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
Vertex Pharmaceuticals VRTX:US $ 482.3M 13.2M
Xencor XNCR:US $ 0M 0M
YTE INCY:US $ 34.19M 0.01M